Merck KGaA (OTCMKTS:MKGAF) Reaches New 52-Week Low – Here’s What Happened

Merck KGaA (OTCMKTS:MKGAF) shares hit a new 52-week low during trading on Thursday . The company traded as low as $140.01 and last traded at $146.54, with a volume of 1464 shares trading hands. The stock had previously closed at $141.90.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group upgraded shares of Merck KGaA to a “strong-buy” rating in a research note on Thursday, September 19th.

Merck KGaA Price Performance

The company has a market cap of $18.94 billion, a price-to-earnings ratio of 22.37 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company has a fifty day moving average price of $154.78 and a two-hundred day moving average price of $169.61.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.